Importantly MRI measurements have shown a correlation with both pathological changes and expression of DUX4 target genes (Wang et al., 2019), but not with immunosuppressive treatments for FSHD (Wang et al., 2021a). The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.